BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33116735)

  • 1. Sustained Stimulation of β
    Pei J; Xiao Z; Guo Z; Pei Y; Wei S; Wu H; Wang D
    Diabetes Metab Syndr Obes; 2020; 13():3887-3898. PubMed ID: 33116735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-permeable tastants amplify β2-adrenergic receptor signaling and delay receptor desensitization via intracellular inhibition of GRK2's kinase activity.
    Malach E; Shaul ME; Peri I; Huang L; Spielman AI; Seger R; Naim M
    Biochim Biophys Acta; 2015 Jul; 1850(7):1375-88. PubMed ID: 25857770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin inhibits cardiac contractility by inducing a Gi-biased β2-adrenergic signaling in hearts.
    Fu Q; Xu B; Liu Y; Parikh D; Li J; Li Y; Zhang Y; Riehle C; Zhu Y; Rawlings T; Shi Q; Clark RB; Chen X; Abel ED; Xiang YK
    Diabetes; 2014 Aug; 63(8):2676-89. PubMed ID: 24677713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aβ monomer induces phosphorylation of Tau at Ser-214 through β2AR-PKA-JNK signaling pathway.
    Wu H; Wei S; Huang Y; Chen L; Wang Y; Wu X; Zhang Z; Pei Y; Wang D
    FASEB J; 2020 Apr; 34(4):5092-5105. PubMed ID: 32067279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.
    Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG
    Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of β
    Susec M; Sencanski M; Glisic S; Veljkovic N; Pedersen C; Drinovec L; Stojan J; Nøhr J; Vrecl M
    Neuropharmacology; 2019 Jul; 152():78-89. PubMed ID: 30707913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling.
    Xin W; Tran TM; Richter W; Clark RB; Rich TC
    J Gen Physiol; 2008 Apr; 131(4):349-64. PubMed ID: 18347080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic receptor mediated protection against doxorubicin-induced apoptosis in cardiomyocytes: the impact of high ambient glucose.
    Yano N; Suzuki D; Endoh M; Tseng A; Stabila JP; McGonnigal BG; Zhao TC; Padbury JF; Tseng YT
    Endocrinology; 2008 Dec; 149(12):6449-61. PubMed ID: 18719028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoproterenol-induced beta-2 adrenergic receptor activation negatively regulates interleukin-2 signaling.
    Ruiz-Medina BE; Cadena-Medina DA; Esparza E; Arrieta AJ; Kirken RA
    Biochem J; 2018 Sep; 475(18):2907-2923. PubMed ID: 30120106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.
    Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK
    Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway.
    Carie AE; Sebti SM
    Oncogene; 2007 May; 26(26):3777-88. PubMed ID: 17260025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor-2 negatively regulates β-adrenergic receptor mediated Ca(2+) dependent signaling pathways in H9c2 cells.
    Somvanshi RK; Zou S; Qiu X; Kumar U
    Biochim Biophys Acta; 2014 Apr; 1843(4):735-45. PubMed ID: 24412308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin induces IRS2-dependent and GRK2-mediated β2AR internalization to attenuate βAR signaling in cardiomyocytes.
    Fu Q; Xu B; Parikh D; Cervantes D; Xiang YK
    Cell Signal; 2015 Mar; 27(3):707-15. PubMed ID: 25460042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-3 protects diabetic hearts from acute myocardial infarction/reperfusion injury through β2AR, cAMP/PKA, and BDNF/TrkB signaling pathways.
    Gong J; Zhou F; Wang SXX; Xu J; Xiao F
    Aging (Albany NY); 2020 Jul; 12(14):14300-14313. PubMed ID: 32692723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
    Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
    J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors.
    Kellenberger S; Muller K; Richener H; Bilbe G
    Bone; 1998 May; 22(5):471-8. PubMed ID: 9600780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTH receptor: ectopic expression, activity and signaling.
    Forti FL; Dias MH; Armelin HA
    Mol Cell Biochem; 2006 Dec; 293(1-2):147-60. PubMed ID: 16845490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.
    Wang D; Fu Q; Zhou Y; Xu B; Shi Q; Igwe B; Matt L; Hell JW; Wisely EV; Oddo S; Xiang YK
    J Biol Chem; 2013 Apr; 288(15):10298-307. PubMed ID: 23430246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilong prevents the high-KCl cardioplegic solution administration-induced apoptosis in H9c2 cardiomyoblast cells mediated by MEK.
    Han CK; Kuo WW; Shen CY; Chen TS; Pai P; Tsai CH; Lo FY; Ju DT; Huang CY
    Am J Chin Med; 2014; 42(6):1507-19. PubMed ID: 25482676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoproterenol induced hypertrophy and associated signaling pathways are modulated by somatostatin in H9c2 cells.
    Somvanshi RK; Qiu X; Kumar U
    Int J Cardiol; 2013 Aug; 167(3):1012-22. PubMed ID: 22465343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.